Skip to main content
. Author manuscript; available in PMC: 2013 May 14.
Published in final edited form as: Biomacromolecules. 2012 Apr 27;13(5):1438–1447. doi: 10.1021/bm300150q

Figure 4.

Figure 4

(A) HIV-1HXB2 viral infectivity inhibition by the IgG1 b12 antibody and side chain peptidesynthetic polymer conjugates 16, 18, and 20. As controls, a copolymer containing a scrambled peptide (26) and the CDRH3 peptide alone are included. The error bars are the standard error observed within one experiment. (B) Efficacy of the polyvalent peptide copolymers against HIV-1 HXB2 wild type on HOS CCR5 cells. The error bars depict the standard error over three or more independent experiments.